Contact Supplier

Contact Supplier

To get in touch with MEGGLE Excipients, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier


    MEGGLE to feature excipient ‘hot topics’ at CPhI North America

    news-releasesMEGGLE Excipients
    May 5th 2022

    Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE Business Unit Excipients (MEGGLE) will continue its campaign of North American events when it appears as a high profile co-exhibitor at the upcoming CPhI North America trade fair in Philadelphia.

    MEGGLE’s appearance in Pennsylvania will follow its simultaneous appearances at twin events in Orlando, Florida, the Respiratory Drug Delivery (RDD) conference opening May 1 and the Excipient World Conference & Expo in nearby Kissimmee.

    Hot topic links

    At CPhI NA 2022, MEGGLE will exhibit digitally via display from the stand of its North American distributor, LBB Specialties, at Booths 1115 &1515 as part of the main CPhI Ingredients and Excipients Zone.

    A particular feature of the MEGGLE display will be interactive exhibits on the three industry ‘hot topics’ of Continuous Manufacturing (CM), Dry Powder Inhalation (DPI) and Orally Disintegrating Tablets (ODTs). Visitors will be able to interact with digital QR codes to connect directly with specific website landing pages for each of these topics.

    Continuous manufacturing applications

    The event will also introduce Jonas Hummel as MEGGLE’s new Head of Sales and area manager for the North American market. Visitors will also be able to get expert advice on advanced excipient applications from LBB’s Troy Austin and Stephanie Mashburn, who will be leading the on stand team.

    LBB stand presentations will focus on the potential of MEGGLE excipients to aid developers in DPI applications, in fast dissolving excipients of ODT formulations and in Continuous Manufacturing (CM) processes.

    About MEGGLE Wasserburg

    Bavarian-based MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.

    MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

    A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage forms and DPI applications, where they can deliver maximum performance.

    The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for sustained release formulations.

    To learn more, visit:

    About CPhI North America

    CPhI North America made its debut in 2017 as a new development of the highly successful CPhI worldwide franchise first established in 1989. Originally conceived as a chemical and pharmaceutical ingredients show, CPhI is now a global series of events for the whole pharmaceutical value chain, taking in events all over the world attracting more than 100,000 attendees annually.

    CPhI NA is branded as seven shows in one, co-locating CPhI Connect for pharmaceutical ingredients with six other zones, including Informex (fine and specialty chemicals), iCSE (drugs development) FDF (finished drug products), P-Mec (Machinery), and InnoPack for packaging.

    The fifth CPhI North America Expo is a hybrid ‘Smart Event’, combining all the face to face interaction of being onsite with an online platform to form a holistic event.

    The three-day face-to-face expo opens  May 17, 2022, once again at the Pennsylvania Convention Center in Philadelphia, preceded by an online seminar program covering three tracks: US Market Insights, Product Innovation and Future Forecasting, Diversity, Equality, and Inclusion, as well as networking via Informa’s new Swapcard platform.

    CPhI North America is staged by leading Global B2B event’s organizer and publisher Informa, with further information at:


    Click on MEGGLE at CPHI North America 2022 to connect with LBB Stand.
    Click on Highest quality for dry powder inhalation for further information.
    Click on MEGGLE’s alpha-lactose monohydrate qualities for dry powder inhalation to download product information.
    Click on MEGGLE DPI technologies to view video.


    Experts in Excipients - The whole world of Lactose

    MEGGLE to feature excipient ‘hot topics’ at CPhI North America
    MEGGLE to feature excipient ‘hot topics’ at CPhI North America

    MEGGLE InhaLac® sieved, milled and micronized lactose-based excipients support a wide range of Dry Powder Inhalation (DPI) applications.

    MEGGLE to feature excipient ‘hot topics’ at CPhI North America

    MEGGLE’s sophisticated co-processed and agglomerated lactose-based excipients support the increasing trend towards Continuous Manufacturing wet and dry granulation processes.

    MEGGLE to feature excipient ‘hot topics’ at CPhI North America

    MEGGLE’s co-processed RetaLac® lactose-based excipients assist developers in perfecting ODT formulations for sustained release.

    Contact MEGGLE Excipients

    Simply fill out the form below to contact MEGGLE Excipients now.

    Send MEGGLE Excipients a Message